Natera

-$1.68 (-1.59%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Natera and other stocks, options, and ETFs commission-free!

About NTRA

Natera, Inc. Common Stock, also called Natera, is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services.

CEO
Stephen Chapman
Employees
1,815
Headquarters
Austin, Texas
Founded
2003

NTRA Key Statistics

Market Cap
9.14B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
947.22K
High Today
$106.42
Low Today
$102.75
Open Price
$105.61
Volume
1.06M
52 Week High
$127.19
52 Week Low
$39.43

NTRA News

ABC NewsJun 10

Cutting-edge test detects early tumor recurrence in some cancers

A new blood test seeks to change the game in cancer management. Signatera, a "tumor-informed" blood test developed by Natera, can detect circulating tumor DNA

NTRA Earnings

-$1.02
-$0.68
-$0.34
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 4, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure